US EditionB.C. Physician Honoured for 'Visionary' Organ Transplant Work
BRITISH COLUMBIA, CANADA, JUL 30 – Dr. Paul Keown has led pioneering clinical trials that reduced kidney transplant rejection rates from 80% to much lower levels, advancing organ matching and immunology research.
- A Delta physician was honoured this year when Dr. Paul Anthony Keown received the Clinic Trials BC Leadership and Advocacy Award, recognizing his contributions over half a century.
- At a time when transplants were nascent, Dr. Paul Anthony Keown, a clinician and trialist with four decades of contributions, was honored for his pioneering work in British Columbia.
- In Victoria, his team studied rejection proteins, and this summer launched the first 'epitope matching' trial across Canadian transplant centres, Dr. Keown said.
- His work has contributed to lowering rejection rates within six months through immune-blocking trials and better matching, improving outcomes for transplant recipients.
- His next goal is a multi-partner study supported by Genome BC, Genome Canada, Michael Smith Health Research BC, and Vancouver Coastal Health Research Institute, aiming to eliminate immune suppressing drugs.
Insights by Ground AI
Does this summary seem wrong?
7 Articles
7 Articles
Coverage Details
Total News Sources7
Leaning Left6Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
